The effects of 5-fluorouracil on the proteome of colon cancer cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Proteome Research

• Publication date

  2013-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/pr400052pPMID 23477467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemosensory proteins, major salivary factors in caterpillar mandibular glands.

  2012cited by this paper
• A new PICTure of nucleolar stress

  2012cited by this paper
• Ribosomal protein S3 interacts with TRADD to induce apoptosis through caspase dependent JNK activation.

  2012cited by this paper
• Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.

  2012cited by this paper
• CBX3 regulates efficient RNA processing genome-wide

  2012cited by this paper
• Reciprocal repression between P53 and TCTP

  2011cited by this paper
• Drug target identification from protein dynamics using quantitative pathway analysis.

  2011cited by this paper
• Interaction profiling identifies the human nuclear exosome targeting complex.

  2011cited by this paper
• UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation

  2011cited by this paper
• The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6

  2011cited by this paper
• mTOR: from growth signal integration to cancer, diabetes and ageing

  2010cited by this paper
• Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.

  2010cited by this paper
• Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels*

  2010cited by this paper
• HINT1 inhibits β‐catenin/TCF4, USF2 and NFκB activity in human hepatoma cells

  2009cited by this paper
• Participation of DNA repair in the response to 5-fluorouracil

  2009cited by this paper
• The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

  2008cited by this paper
• BMC Bioinformatics BioMed Central

  2008cited by this paper
• The RNA Exosome Component hRrp6 Is a Target for 5-Fluorouracil in Human Cells

  2008cited by this paper
• Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

  2008cited by this paper
• STRING 8—a global view on proteins and their functional interactions in 630 organisms

  2008cited by this paper
• Dynamic Proteomics of Individual Cancer Cells in Response to a Drug

  2008cited by this paper
• Identification of dominant signaling pathways from proteomics expression data.

  2008cited by this paper
• RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p

  2008cited by this paper
• The exosome: a multipurpose RNA-decay machine.

  2008cited by this paper
• Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers

  2006cited by this paper
• Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo

  2006cited by this paper
• Correction: Directed Migration of Positively Selected Thymocytes Visualized in Real Time

  2005cited by this paper
• Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes.

  2004cited by this paper
• 5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs

  2004cited by this paper
• Predictive markers for colorectal cancer: current status and future prospects.

  2003cited by this paper
• Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

  2003cited by this paper
• Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.

  2002cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.

  1994cited by this paper
• 5-Fluorouracil substitution alters pre-mRNA splicing in vitro.

  1988cited by this paper
• Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine.

  1973cited by this paper

• NAIL-MS reveals tRNA and rRNA hypomodification as a consequence of 5-fluorouracil treatment

  2025cites this paper
• STK32C as a Therapeutic Target in Colorectal Cancer via HSP90-PI3K/AKT/mTOR Signaling

  2025cites this paper
• Biomineralized Cu-Disulfiram nanoparticles Potentiate Colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis

  2025cites this paper
• A bacterial genotoxin reveals a p53-proteasome-LC3 regulatory axis that drives the suppression of autophagy in cells experiencing sublethal DNA damage

  2025cites this paper
• Translational control of cell plasticity drives 5-FU tolerance

  2024cites this paper
• Temporal placement of RNA modifications under 5-fluorouracil treatment in human cell culture

  2024cites this paper
• Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways

  2024cites this paper
• AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death.

  2024cites this paper
• Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway

  2024cites this paper
• ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

  2023cites this paper
• Martynoside rescues 5-fluorouracil-impaired ribosome biogenesis by stabilizing RPL27A.

  2023cites this paper
• Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells

  2022cites this paper
• Changes in Pharmacodynamic Parameters during Co-administration of 5-FU with Warfarin: A Retrospective Case Series.

  2022cites this paper
• CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity.

  2021cites this paper
• Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death

  2021cites this paper
• Treatment With Medicinal Mushroom Extract Mixture Inhibits Translation and Reprograms Metabolism in Advanced Colorectal Cancer Animal Model as Evidenced by Tandem Mass Tags Proteomics Analysis

  2020cites this paper
• Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells

  2020cites this paper
• Proteome Integral Solubility Alteration (PISA): a high-throughput proteomics assay for target deconvolution.

  2019cites this paper
• The anti-cancer drug 5-fluorouracil affects cell cycle regulators and potential regulatory long non-coding RNAs in yeast

  2019cites this paper
• Conflicting alterations in hepatic expression of CYP3A and enzyme kinetics in rats exposed to 5-fluorouracil: relevance to pharmacokinetics of midazolam

  2019cites this paper
• ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery

  2019cites this paper
• Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions*

  2018cites this paper
• Proteome Integral Stability Alteration assay dramatically increases throughput and sensitivity in profiling factor-induced proteome changes

  2018cites this paper
• ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery

  2018cites this paper
• The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

  2018cites this paper
• Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.

  2017cites this paper
• In vitro/in vivo study of novel anti-cancer, biodegradable cross-linked tannic acid for fabrication of 5-fluorouracil-targeting drug delivery nano-device based on a molecular imprinted polymer

  2016cites this paper
• 5-Fluorouracil mediated cell death signaling in colon carcinoma cells

  2016cites this paper
• How well can morphology assess cell death modality? A proteomics study

  2016cites this paper
• DFT explorations of quadrupole coupling constants for planar 5-fluorouracil pairs

  2016cites this paper
• 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53

  2015cites this paper
• Proteomics in mechanistic toxicology: History, concepts, achievements, caveats, and potential

  2015cites this paper
• Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

  2015cites this paper
• Effect of 5-Fluorouracil on translational regulation in colorectal cancer cells

  2015cites this paper
• Clinical Diagnosis and Therapy of Colorectal Cancer Chapter : Treatment of Colorectal Cancer Liver Metastases : Clinical and Molecular Aspects

  2015cites this paper
• Comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells.

  2015cites this paper
• Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs

  2015cites this paper
• Expression proteomics reveals protein targets and highlights mechanisms of action of small molecule drugs

  2014cites this paper
• Gene expression profile of 5-fluorouracil metabolic enzymes in laryngeal cancer cell line: predictive parameters for response to 5-fluorouracil-based chemotherapy.

  2014influential citation
• Cytostatic/Cytotoxic Effects of 5‐Fluorouridine Nucleolipids on Colon, Hepatocellular, and Renal Carcinoma Cells: in vitro Identification of a Potential Cytotoxic Multi‐Anticancer Drug

  2014cites this paper
• Synthesis of 5‐Fluorouridine Nucleolipid Derivatives and Their Cytostatic/Cytotoxic Activities on Human HT‐29 Colon Carcinoma Cells

  2013cites this paper